ArticleJournal of cellular and molecular medicine2020

Inhibition of PLK4 might enhance the anti-tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway.

Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.